María
Hernández Sánchez
Investigadora Predoctoral en Formación
Chercheuse dans le période 2013-2017
Publications (39) Publications de María Hernández Sánchez
2025
-
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker
Leukemia, Vol. 39, Núm. 7, pp. 1650-1660
-
SAMHD1 dysfunction impairs DNA damage response and increases sensitivity to PARP inhibition in chronic lymphocytic leukemia
Scientific Reports, Vol. 15, Núm. 1
2023
-
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions
Cancer Genetics, Vol. 272-273, pp. 16-22
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
2022
-
TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914
-
Uso de las redes sociales Twitter e Instagram como herramientas docentes para la enseñanza de la genética clínica en la Universidad de Salamanca
La necesidad de la transformación social desde la innovación docente y educativa (Aula Magna), pp. 261-279
-
Uso de las redes sociales de Twitter e Instagram como herramientas docentes para la enseñanza de la genética clínica en la Universidad de Salamanca
Educación y transferencia del conocimiento: propuesta de innovación para la mejora docente
2021
-
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
Blood Cancer Journal, Vol. 11, Núm. 7
-
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
Clinical and Translational Medicine, Vol. 11, Núm. 2
-
From biomarkers to models in the changing landscape of chronic lymphocytic leukemia: Evolve or become extinct
Cancers, Vol. 13, Núm. 8
-
The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment
Diagnostics, Vol. 11, Núm. 5
2020
-
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
Leukemia, Vol. 34, Núm. 6, pp. 1599-1612
-
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792
-
Integrated genomic analysis of chromosomal alterations and mutations in B-cell acute lymphoblastic leukemia reveals distinct genetic profiles at relapse
Diagnostics, Vol. 10, Núm. 7
-
Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?
Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 8, pp. 548-555.e4
2019
-
1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia
Clinical and Experimental Medicine, Vol. 19, Núm. 2, pp. 261-267
-
CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
Leukemia, Vol. 33, Núm. 2, pp. 518-558
-
DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains
Experimental Hematology, Vol. 72, pp. 9-13
2018
-
Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 3, pp. 633-642